{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T12:21:23Z","timestamp":1790511683990,"version":"4.1.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,5,31]],"date-time":"2021-05-31T00:00:00Z","timestamp":1622419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,5,31]],"date-time":"2021-05-31T00:00:00Z","timestamp":1622419200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Ministry of\u00a0Human\u00a0Resources\u00a0and\u00a0Social Security\u00a0of the People\u2019s Republic of China","award":["2015-192"],"award-info":[{"award-number":["2015-192"]}]},{"DOI":"10.13039\/501100012173","name":"China-Japan Friendship Hospital","doi-asserted-by":"publisher","award":["2015-1-QN-1"],"award-info":[{"award-number":["2015-1-QN-1"]}],"id":[{"id":"10.13039\/501100012173","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Charcot\u2013Marie\u2013Tooth (CMT) disease is an exciting field of study, with a growing number of causal genes and an expanding phenotypic spectrum. The microrchidia family CW-type zinc finger 2 gene (MORC2) was newly identified as a causative gene of CMT2Z in 2016. We aimed to describe the phenotypic-genetic spectrum of MORC2-related diseases in the Chinese population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>With the use of Sanger sequencing and Next Generation Sequencing (NGS) technologies, we screened a cohort of 284 unrelated Chinese CMT2 families. Pathogenicity assessments of MORC2 variants were interpreted according to the ACMG guidelines. Potential pathogenic variants were confirmed by Sanger sequencing.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We identified 4 different heterozygous MORC2 mutations in four unrelated families, accounting for 1.4% (4\/284). A novel mutation c.1397A&gt;G p. D466G was detected in family 1 and all affected patients presented with later onset axonal CMT with hyperCKemia. The patient in family 2 showed a spinal muscular atrophy (SMA)-like disease with cerebellar hypoplasia and mental retardation, with a hot spot de novo mutation c.260C&gt;T p. S87L. The twin sisters in family 3 were identified as having the most common mutation c.754C&gt;T p. R252W and suffered from axonal motor neuropathy with high variability in disease severity and duration. The patient in family 4 developed an early onset axonal motor and sensory neuropathy, with a reported mutation c.1220G&gt;A p.C407Y. All identified mutations associated with MORC2-related neuropathies are localized in the N-terminal ATPase module.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our study confirmed that MORC2-related neuropathies exist in the Chinese population at a relatively high mutation rate. We revealed a complex genotype\u2013phenotype correlation with MORC2 mutations. This report adds a new piece to the puzzle of the genetics of CMT and contributes to a better understanding of the disease mechanisms.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13023-021-01881-7","type":"journal-article","created":{"date-parts":[[2021,6,4]],"date-time":"2021-06-04T05:29:16Z","timestamp":1622784556000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Characterization of genotype\u2013phenotype correlation with MORC2 mutated Axonal Charcot\u2013Marie\u2013Tooth disease in a cohort of Chinese patients"],"prefix":"10.1186","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5916-4569","authenticated-orcid":false,"given":"Xiaohui","family":"Duan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guochun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weihong","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingrui","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaojie","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuting","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenhua","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongsheng","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renbin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuwei","family":"Da","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,31]]},"reference":[{"issue":"10","key":"1881_CR1","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1038\/nrneurol.2013.179","volume":"9","author":"AM Rossor","year":"2013","unstructured":"Rossor AM, Polke JM, Houlden H, Reilly MM. Clinical implications of genetic advances in Charcot\u2013Marie\u2013Tooth disease. Nat Rev Neurol. 2013;9(10):562\u201371.","journal-title":"Nat Rev Neurol"},{"key":"1881_CR2","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1093\/brain\/awv311","volume":"139","author":"T Sevilla","year":"2016","unstructured":"Sevilla T, Lupo V, Mart\u00ednez-Rubio D, Sancho P, Sivera R, Chumillas MJ, et al. Mutations in the MORC2 gene cause axonal Charcot\u2013Marie\u2013Tooth disease. Brain. 2016;139:62\u201372.","journal-title":"Brain"},{"key":"1881_CR3","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1016\/j.celrep.2012.11.018","volume":"2","author":"DQ Li","year":"2012","unstructured":"Li DQ, Nair SS, Ohshiro K, Kumar A, Nair VS, Pakala SB, et al. MORC2 signaling integrates phosphorylation-dependent, ATPase-coupled chromatin remodeling during the DNA damage response. Cell Rep. 2012;2:1657\u201369.","journal-title":"Cell Rep"},{"key":"1881_CR4","doi-asserted-by":"publisher","first-page":"685","DOI":"10.4161\/epi.24976","volume":"8","author":"DQ Li","year":"2013","unstructured":"Li DQ, Nair SS, Kumar R. The MORC family: new epigenetic regulators of transcription and DNA damage response. Epigenetics. 2013;8:685\u201393.","journal-title":"Epigenetics"},{"issue":"7","key":"1881_CR5","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1038\/ng.3878","volume":"49","author":"IA Tchasovnikarova","year":"2017","unstructured":"Tchasovnikarova IA, Timms RT, Douse CH, Roberts RC, Dougan G, Kingston RE, et al. Hyperactivation of HUSH complex function by Charcot\u2013Marie\u2013Tooth disease mutation in MORC2. Nat Genet. 2017;49(7):1035\u201344.","journal-title":"Nat Genet"},{"key":"1881_CR6","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/s41467-018-03045-x","volume":"9","author":"CH Douse","year":"2018","unstructured":"Douse CH, Bloor S, Liu Y, Shamin M, Tchasovnikarova IA, Timms RT, et al. Neuropathic MORC2 mutations perturb GHKL ATPase dimerization dynamics and epigenetic silencing by multiple structural mechanisms. Nat Commun. 2018;9:651.","journal-title":"Nat Commun"},{"key":"1881_CR7","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1002\/ana.24575","volume":"79","author":"OM Albulym","year":"2016","unstructured":"Albulym OM, Kennerson ML, Harms MB, Drew AP, Siddell AH, Auer-Grumbach M, et al. MORC2 mutations cause axonal Charcot\u2013Marie\u2013Tooth disease with pyramidal signs. Ann Neurol. 2016;79:419\u201327.","journal-title":"Ann Neurol"},{"key":"1881_CR8","doi-asserted-by":"publisher","first-page":"e26","DOI":"10.1093\/brain\/awv411","volume":"139","author":"P Lassuthova","year":"2016","unstructured":"Lassuthova P, Safka BD, Krutova M, Mazanec R, Zuchner S, Gonzalez MA, et al. Severe axonal Charcot\u2013Marie\u2013Tooth disease with proximal weakness caused by de novo mutation in the MORC2 gene. Brain. 2016;139:e26.","journal-title":"Brain"},{"key":"1881_CR9","doi-asserted-by":"publisher","first-page":"e40","DOI":"10.1093\/brain\/aww082","volume":"139","author":"YS Hyun","year":"2016","unstructured":"Hyun YS, Hong YB, Choi BO, Chung KW. Clinico-genetics in Korean Charcot\u2013Marie\u2013Tooth disease type 2Z with MORC2 mutations. Brain. 2016;139:e40.","journal-title":"Brain"},{"key":"1881_CR10","doi-asserted-by":"publisher","first-page":"e56","DOI":"10.1093\/brain\/aww156","volume":"139","author":"X Zhao","year":"2016","unstructured":"Zhao X, Li X, Hu Z, Liu L, Xie Y, Tian T, et al. MORC2 mutations in a cohort of Chinese patients with Charcot\u2013Marie\u2013Tooth disease type 2. Brain. 2016;139:e56.","journal-title":"Brain"},{"key":"1881_CR11","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1212\/WNL.0000000000003772","volume":"88","author":"B Bansagi","year":"2017","unstructured":"Bansagi B, Griffin H, Whittaker RG, Antoniadi T, Evangelista T, Miller J, et al. Genetic heterogeneity of motor neuropathies. Neurology. 2017;88:1226\u201334.","journal-title":"Neurology"},{"key":"1881_CR12","doi-asserted-by":"publisher","first-page":"e70","DOI":"10.1093\/brain\/aww252","volume":"139","author":"G Schottmann","year":"2016","unstructured":"Schottmann G, Wagner C, Seifert F, Stenzel W, Schuelke M. MORC2 mutation causes severe spinal muscular atrophy-phenotype, cerebellar atrophy, and diaphragmatic paralysis. Brain. 2016;139:e70.","journal-title":"Brain"},{"key":"1881_CR13","doi-asserted-by":"publisher","first-page":"e21","DOI":"10.1093\/brain\/awx019","volume":"140","author":"C Semplicini","year":"2017","unstructured":"Semplicini C, Ollagnon-Roman E, Leonard-Louis S, Piguet-Lacroix G, Silvestre M, Latour P, et al. High intra-familiar clinical variability in MORC2 mutated CMT2 patients. Brain. 2017;140:e21.","journal-title":"Brain"},{"key":"1881_CR14","doi-asserted-by":"publisher","first-page":"e34","DOI":"10.1093\/brain\/awx083","volume":"140","author":"G Zanni","year":"2017","unstructured":"Zanni G, Nardella M, Barresi S, Bellacchio E, Niceta M, Ciolfi A, et al. De novo p.T362R mutation in MORC2 causes early onset cerebellar ataxia, axonal polyneuropathy and nocturnal hypoventilation. Brain. 2017;140:e34.","journal-title":"Brain"},{"key":"1881_CR15","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1111\/ene.13360","volume":"24","author":"M Ando","year":"2017","unstructured":"Ando M, Okamoto Y, Yoshimura A, Yuan JH, Hiramatsu Y, Higuchi Y, et al. Clinical and mutational spectrum of Charcot\u2013Marie\u2013Tooth disease type 2Z caused by MORC2 variants in Japan. Eur J Neurol. 2017;24:1274\u201382.","journal-title":"Eur J Neurol"},{"issue":"9","key":"1881_CR16","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1002\/humu.23560","volume":"39","author":"M Karakaya","year":"2018","unstructured":"Karakaya M, Storbeck M, Strathmann EA, DelleVedove A, H\u00f6lker I, Altmueller J, et al. Targeted sequencing with expanded gene profile enables high diagnostic yield in non-5q-spinal muscular atrophies. Hum Mutat. 2018;39(9):1284\u201398.","journal-title":"Hum Mutat"},{"issue":"7","key":"1881_CR17","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/S1474-4422(09)70110-3","volume":"8","author":"D Pareyson","year":"2009","unstructured":"Pareyson D, Marchesi C. Diagnosis, natural history, and management of Charcot\u2013Marie\u2013Tooth disease. Lancet Neurol. 2009;8(7):654\u201367.","journal-title":"Lancet Neurol"},{"key":"1881_CR18","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.nmd.2010.08.001","volume":"20","author":"MM Reilly","year":"2010","unstructured":"Reilly MM, Shy ME, Muntoni F, Pareyson D. 168th ENMC international workshop: outcome measures and clinical trials in Charcot\u2013Marie\u2013Tooth disease (CMT). Neuromuscul Disord. 2010;20:839\u201346.","journal-title":"Neuromuscul Disord"},{"issue":"5","key":"1881_CR19","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17(5):405\u201324.","journal-title":"Genet Med"},{"issue":"9","key":"1881_CR20","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/j.clineuro.2010.05.001","volume":"112","author":"M Luigetti","year":"2010","unstructured":"Luigetti M, Modoni A, Renna R, Silvestri G, Ricci E, Montano N, et al. A case of CMT 1B due to Val 102\/fs null mutation of the MPZ gene presenting as hyperCKemia. Clin Neurol Neurosurg. 2010;112(9):794\u20137.","journal-title":"Clin Neurol Neurosurg"},{"issue":"10","key":"1881_CR21","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1111\/j.1468-1331.2006.01479.x","volume":"13","author":"J Finsterer","year":"2006","unstructured":"Finsterer J, Miltenberger G, Rauschka H, Janecke A. Novel C59T leader peptide mutation in the MPZ gene associated with late-onset, axonal, sensorimotor polyneuropathy. Eur J Neurol. 2006;13(10):1149\u201352.","journal-title":"Eur J Neurol"},{"issue":"5","key":"1881_CR22","doi-asserted-by":"publisher","first-page":"335","DOI":"10.5414\/NP300742","volume":"33","author":"M Elbracht","year":"2014","unstructured":"Elbracht M, Senderek J, Schara U, Nolte K, Klopstock T, Roos A, et al. Clinical and morphological variability of the E396K mutation in the neurofilament light chain gene in patients with Charcot\u2013Marie\u2013Tooth disease type 2E. Clin Neuropathol. 2014;33(5):335\u201343.","journal-title":"Clin Neuropathol"},{"issue":"3","key":"1881_CR23","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1002\/ana.10681","volume":"54","author":"K Szigeti","year":"2003","unstructured":"Szigeti K, Saifi GM, Armstrong D, Belmont JW, Miller G, Lupski JR. Disturbance of muscle fiber differentiation in congenital hypomyelinating neuropathy caused by a novel myelin protein zero mutation. Ann Neurol. 2003;54(3):398\u2013402.","journal-title":"Ann Neurol"},{"issue":"10","key":"1881_CR24","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1093\/hmg\/ddz006","volume":"28","author":"P Sancho","year":"2019","unstructured":"Sancho P, Bartesaghi L, Miossec O, Garc\u00eda-Garc\u00eda F, Ram\u00edrez-Jim\u00e9nez L, Siddell A, et al. Characterization of molecular mechanisms underlying the axonal Charcot\u2013Marie\u2013Tooth neuropathy caused by MORC2 mutations. Hum Mol Genet. 2019;28(10):1629\u201344.","journal-title":"Hum Mol Genet"},{"issue":"1","key":"1881_CR25","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/s12964-019-0477-5","volume":"17","author":"HY Xie","year":"2019","unstructured":"Xie HY, Zhang TM, Hu SY, Shao ZM, Li DQ. Dimerization of MORC2 through its C-terminal coiled-coil domain enhances chromatin dynamics and promotes DNA repair. Cell Commun Signal. 2019;17(1):160.","journal-title":"Cell Commun Signal"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-021-01881-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-021-01881-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-021-01881-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,4]],"date-time":"2021-06-04T05:36:31Z","timestamp":1622784991000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-021-01881-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,31]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1881"],"URL":"https:\/\/doi.org\/10.1186\/s13023-021-01881-7","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,31]]},"assertion":[{"value":"29 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of China-Japan Friendship Hospital (NO.2013-39, NO.2019-166-K115), Peking University Third Hospital (IRB 00006761).Written informed consent was obtained from the patients or their parents involved in this study. They consented to the publication of clinical photographs.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"A consent to publish form was signed by all the patients who were included in our study. For the children, their parents or legal guardians signed the consent form.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"244"}}